Novo Nordisk A/S (NVO)
51.23
-0.42 -0.81%
NYSE
Oct 11, 20:00
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 17.85B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.393 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 5.741B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 83.86% |
| Profit Margin (Quarterly) | 31.94% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 2.44% |
| Price and Valuation | |
| Market Cap | 121.12B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 6.891 |
| PE Ratio (TTM) | 21.41 |
| Price to Book Value | 14.98 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.0797 |
| Free Cash Flow (Quarterly) | 1.833B |
| Return on Equity (TTM) | Upgrade |
View All NVO News
News
-
WireHeadlineTime (ET)
-
Yahoo10/13 17:15
-
Yahoo10/11 11:03
-
MT Newswires10/11 10:38
-
Yahoo10/11 09:19
-
Yahoo10/10 11:17
-
Yahoo10/09 20:12
-
Yahoo10/09 17:33
-
MT Newswires10/09 09:14
-
SA Breaking News10/09 08:16
-
Yahoo10/07 09:08
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 05/01/2020 | Earnings | Novo Nordisk A/S First Quarter Earnings Results in 2020 |
| 02/05/2020 | Earnings | Novo Nordisk A/S Fourth Quarter Earnings Results in 2019 |
| 11/01/2019 | Earnings | Novo Nordisk A/S Third Quarter Earnings Results in 2019 |
| 08/09/2019 | Earnings | Novo Nordisk A/S Second Quarter Earnings in 2019 Release |
| 05/03/2019 | Earnings | Novo Nordisk A/S First Quarter Earnings Results in 2019 |
| 03/22/2019 | Dividends | Amount: 0.7887, Declared Date: Feb 05 2019, Pay Date: Apr 02 2019 |
| 03/21/2019 | Misc | Novo Nordisk A/S Annual General Meeting in 2018 |
| 02/04/2019 | Earnings | Novo Nordisk A/S Fourth Quarter Earnings Results in 2018 |
| 02/04/2019 | Misc | Novo Nordisk A/S Annual Report in 2018 |
| 11/01/2018 | Earnings | Novo Nordisk A/S Third Quarter Earnings Results in 2018 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.novonordisk.com
- Investor Relations URL: http://www.novonordisk.com/investors.html
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Large Cap/Growth
- Next Earnings Release: Nov. 01, 2019
- Last Earnings Release: Aug. 09, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Mar. 22, 2019
- Description: With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, as well as oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 51.23 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| PPH | VanEck Vectors Pharmaceutical ETF | 5.21% |
| LIFE.TO | Evolve Global Healthcare Enh Yld ETF Hdg | 4.78% |
| ADRU | Invesco BLDRS Europe Select ADR | 2.87% |
| LGRCX | Loomis Sayles Growth C | 2.77% |
| FVUSA000PM | AST Loomis Sayles Large Cap Growth Port | 2.75% |
| USLYX | JHancock US Global Leaders Growth R2 | 2.60% |
| AMIGX | Amana Growth Institutional | 2.44% |
| ADRD | Invesco BLDRS Developed Markets 100 ADR | 2.33% |
| PHLBX | PGIM Jennison Health Sciences B | 2.33% |
| MBCNX | MassMutual Select Blue Chip Growth R3 | 1.20% |
| PTIN | Pacer Trendpilot International ETF | 0.65% |
| AVDE | Avantis™ International Equity ETF | 0.50% |
Excel Add-In Codes
- Name: =YCI("NVO","name")
- Description: =YCI("NVO","description")
- Sector: =YCI("NVO","sector")
- Industry: =YCI("NVO","industry")
- Est. Current Fiscal Year End: =YCI("NVO","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NVO Tweets Stocktwits
Advertisement
